- Filed
- Mar 19, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 134.13M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 91.16M sh |
| Capex | FY 2025 · Dec 31, 2025 | $7.38M |
| Capex | FY 2025 · Dec 31, 2024 | $5.04M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$26.89M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$35.89M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $94.43M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $22.49M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $60.53M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$53.03M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $51.68M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $22.51M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $34.62M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $90.78M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $114.72M |
| Current Assets | FY 2025 · Dec 31, 2025 | $115.17M |
| Current Assets | FY 2025 · Dec 31, 2024 | $27.86M |
| Total Assets | FY 2025 · Dec 31, 2025 | $151.3M |
| Total Assets | FY 2025 · Dec 31, 2024 | $61.69M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.18 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$1.28 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.04 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$1.28 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $25.74M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $32.99M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $5M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $7.5M |
| Net Income | FY 2025 · Dec 31, 2025 | −$4.78M |
| Net Income | FY 2025 · Dec 31, 2024 | −$116.27M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$31.02M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$52.21M |
| Revenue | FY 2025 · Dec 31, 2025 | $17.71M |
| Revenue | FY 2025 · Dec 31, 2024 | $12.87M |